Two UnitedHealth Group senior executives have accepted leadership roles at Talkspace, the online therapy company announced in a recent statement. Dr. Neal Leibowitz, formerly a senior behavioral health medical director at UnitedHealth Group, will become Talkspace’s first chief medical officer, while Deb Adler, a senior vice president at UnitedHealth Group’s Optum, will serve as senior VP of network and quality.
from MobiHealthNews https://ift.tt/2JCD5pS
May 01, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Cash incentives, wearable tracker increase steps for ischemic heart disease patientsA little bit of cash paired with a wearable activity tracker could be key in motivating people with ischemic heart disease to stay active. A recent study, published in the Journal of the American Heart Association, found that… Read More
FDA approves wearable device for opioid withdrawal symptom treatment deviceDyAnsys, a medical device company specializing in the autonomic nervous system, announced this week that it has received FDA approval for a wearable auricular neurostimulation device designed to treat symptoms of opioid withd… Read More
Medical communication tool Medici rakes in $22.4MToday medical communication startup Medici announced that it has raised $22.4 million from executives coming from Citadel, Dell, Publix, and Starwood Capital, and other unnamed investors. The Austin, Texas-based startup is ai… Read More
Study: VA-sponsored telementoring improved survival rates for liver disease by 54 percentPatients of doctors who participated in a Veteran Affairs-run telemedicine consultation program were 54 percent more likely to survive chronic liver disease than a matched cohort of patients of non-participating doctors, acco… Read More
Studies lend credence to Click Therapeutics' digital therapeutic for depressionThe past month has seen a succession of publications offering support for Click Therapeutics’ digital offering for patients with major depressive disorder (MDD). from MobiHealthNews https://ift.tt/2JVMBYW … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment